Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

This Is What Whales Are Betting On Tesla

A whale with a lot of money to spend has taken a noticeably bearish stance on Tesla. Looking at options history for Tesla (NASDAQ:TSLA) we detected 414 strange trades.

Benzinga

Earnings Preview: Apple

Apple (NASDAQ:AAPL) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Apple will report an earnings per share (EPS) of $1.43.

Benzinga

A Preview Of Amazon.com's Earnings

Amazon.com (NASDAQ:AMZN) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Amazon.com will report an earnings per share (EPS) of $8.07.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For Intel

Intel (NASDAQ:INTC) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Intel will report an earnings per share (EPS) of $0.80.

Benzinga

Archegos Founder Bill Hwang Hit With Fraud Charges: What You Need To Know

The U.S. Securities and Exchange Commission has charged Archegos Capital Management founder Sung Kook "Bill" Hwang and Chief Financial Officer Patrick Halligan with 11 criminal counts in connection to the multibillion-dollar implosion of their hedge fund.

Benzinga

Here's How Much $100 Invested In Cadence Design Sys 10 Years Ago Would Be Worth Today

Cadence Design Sys (NASDAQ:CDNS) has outperformed the market over the past 10 years by 17.97% on an annualized basis producing an average annual return of 29.55%. Currently, Cadence Design Sys has a market capitalization of $42.88 billion.

Benzinga

So What's Going On With Vivakor Shares Popping Off?

Vivakor Inc (NASDAQ: VIVK) shares are trading higher by 156.7% at $4.40 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of up to $250 million.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Peering Into SoFi Technologies Inc. - Common Stock's Recent Short Interest

SoFi Technologies Inc. - Common Stock's (NASDAQ:SOFI) short percent of float has fallen 7.91% since its last report. The company recently reported that it has 129.77 million shares sold short, which is 21.43% of all regular shares that are available for trading.

Benzinga

Why Lucid Shares Are Rising Today

Lucid Group Inc (NASDAQ: LCID) shares are trading higher Wednesday after the company announced an agreement with the Government of Saudi Arabia, under which the Government will purchase up to 100,000 vehicles over a ten-year period.

Benzinga

Entegris's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Entegris (NASDAQ:ENTG) earned $125.70 million, a 6.33% increase from the preceding quarter. Entegris also posted a total of $649.65 million in sales, a 2.27% increase since Q4.

Benzinga

Mondelez International's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Mondelez International (NASDAQ:MDLZ) showed a loss in earnings since Q4, totaling $861.00 million. Sales, on the other hand, increased by 1.38% to $7.76 billion during Q1.

Benzinga

Pfizer Injects $25M Via Equity In Zentalis Pharma

Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) will sell 953,834 common shares at $26.21 per share to Pfizer Inc (NYSE:PFE) for $25 million. The offering is expected to close by April 29. Zentalis will use the proceeds to fund ongoing and planned clinical trials, including studies of ZN-c3 and ZN-d5, and for working capital and general corporate…

Benzinga

Kraft Heinz Q1 Earnings Beat Street View

Kraft Heinz Co (NASDAQ:KHC) reported a first-quarter FY22 sales decline of 5.5% year-on-year to $6.04 billion, beating the consensus of $5.83 billion. Sales in the U.S. fell 8.5% Y/Y, International rose 3.6%, and Canada fell 1.5%. Gross profit decreased by 12.3% Y/Y to $1.9 billion, with the margin contracting 250 points to 31.9%.…

Benzinga

PepsiCo Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, PepsiCo (NASDAQ:PEP) posted Q1 earnings of $4.27 billion, an increase from Q4 of 218.64%. Sales dropped to $16.20 billion, a 35.84% decrease between quarters.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

CONFIRMED: Apple Moves Away From Payment Card Manager Discover

A Discover Financial Services (NYSE: DFS) representative gave a statement to Benzinga clarifying its payment card network's role in Apple Inc. (NASDAQ: AAPL) Apple Cash digital payment cards service

Benzinga

Mid-Morning Market Update: Markets Open Higher; Dow Gains 300 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

Benzinga

Farmers National Banc: Q1 Earnings Insights

Farmers National Banc (NASDAQ:FMNB) reported its Q1 earnings results on Wednesday, April 27, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

HomeTrust Bancshares: Q3 Earnings Insights

HomeTrust Bancshares (NASDAQ:HTBI) reported its Q3 earnings results on Wednesday, April 27, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Novartis - BeiGene's Tislelizumab Aces Late-Stage Esophageal Cancer Trial

Novartis AG (NYSE:NVS) has announced topline results from an interim analysis of the Phase 3 RATIONALE 306 study of tislelizumab plus chemotherapy in esophageal squamous cell carcinoma (ESCC). Data showed that tislelizumab plus chemotherapy significantly improved overall survival (OS) compared to chemotherapy in patients with previously untreated unresectable, locally advanced, recurrent, or metastatic…

Benzinga

Benzinga's Daily Brief On Trending Tickers For April 27, 2022: Visa, Robinhood, Enphase Energy, And More

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

Benzinga

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (NYSE:MDT). The combination of these two transactions, taken together with the Company’s recently completed restructuring,…

Benzinga

Stock Yards Bancorp: Q1 Earnings Insights

Stock Yards Bancorp (NASDAQ:SYBT) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

ASLAN Pharma: Q1 Earnings Insights

ASLAN Pharma (NASDAQ:ASLN) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga

Analyst Ratings for PepsiCo

Analysts have provided the following ratings for PepsiCo (NASDAQ:PEP) within the last quarter:

1 … 652 653 654 655

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.